Cargando…

The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke

BACKGROUND: Stroke-associated pneumonia (SAP) is a standout complication after acute ischemic stroke (AIS), with a prevalence of 7–38%. The aim of this prospective study was to investigate the relationship between serum YKL-40 levels at admission and SAP. METHODS: Between August 2020 and February 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Guomei, Chen, Wenxiu, Gong, Pengyu, Wang, Meng, Zhou, Junshan, Wang, Xiaorong, Guo, Minwang, Lu, Jingye, Li, Yan, Feng, Hongxuan, Fu, Xuetao, Zhou, Rujuan, Xue, Shouru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422031/ https://www.ncbi.nlm.nih.gov/pubmed/34511972 http://dx.doi.org/10.2147/JIR.S329612

Ejemplares similares

Prognostic performance of serum YKL-40 for one-year clinical outcomes in acute ischemic stroke
por: Shi, Guomei, et al.
Publicado: (2023)

Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke
por: Shi, Guomei, et al.
Publicado: (2023)

Correlation Between Cognitive Impairment and Homocysteine and S100B Protein in Patients with Progressive Ischemic Stroke
por: Li, Yan, et al.
Publicado: (2023)

Independent Predictive Value of Elevated YKL-40 in Ischemic Stroke Prognosis: Findings from a Nationwide Stroke Registry
por: Qin, Haiqiang, et al.
Publicado: (2023)

Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients
por: Park, Hyun Young, et al.
Publicado: (2012)

Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study
por: Xu, Qingyun, et al.
Publicado: (2023)

Blood pressure excursion on admission and intravenous thrombolysis in ischemic stroke
por: Du, Linzhe, et al.
Publicado: (2023)

Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study
por: Li, Jiejie, et al.
Publicado: (2022)

The Association between High Mobility Group Box 1 and Stroke-Associated Pneumonia in Acute Ischemic Stroke Patients
por: E, Yan, et al.
Publicado: (2022)

Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic Stroke
por: Rathcke, Camilla Noelle, et al.
Publicado: (2012)

Usefulness of Plasma YKL-40 in Management of Community-Acquired Pneumonia Severity in Patients
por: Wang, Hsiang-Ling, et al.
Publicado: (2013)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Neutrophil–lymphocyte ratio predicts post‐thrombolysis early neurological deterioration in acute ischemic stroke patients
por: Gong, Pengyu, et al.
Publicado: (2019)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke
por: Gong, Pengyu, et al.
Publicado: (2021)

YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children
por: Yang, Xingge, et al.
Publicado: (2018)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

The Potential of Gut Microbiota in Prediction of Stroke-Associated Pneumonia
por: Li, Zhongyuan, et al.
Publicado: (2023)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Individualized Prediction Of Stroke-Associated Pneumonia For Patients With Acute Ischemic Stroke
por: Huang, Gui-Qian, et al.
Publicado: (2019)

The Effects of Air Pollution on Ischemic Stroke Admission Rate
por: Alimohammadi, Hossein, et al.
Publicado: (2016)

Plasma YKL-40 Elevation on Admission and Follow-Up Is Associated with Diastolic Dysfunction and Mortality in Patients with Acute Myocardial Infarction
por: Pala, Selcuk, et al.
Publicado: (2018)

Reduced Vitamin D Levels are Associated with Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke
por: Huang, Gui-Qian, et al.
Publicado: (2019)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
por: Wang, Dong, et al.
Publicado: (2012)

Roseburia Abundance Associates With Severity, Evolution and Outcome of Acute Ischemic Stroke
por: Gu, Mengmeng, et al.
Publicado: (2021)

CTX-II and YKL-40 in early diagnosis and treatment evaluation of osteoarthritis
por: Wang, Pengkun, et al.
Publicado: (2019)

YKL-40 Is Associated With Ultrasound-Determined Carotid Atherosclerotic Plaque Instability
por: Wang, Yu, et al.
Publicado: (2021)

Gut Microbiota Dysbiosis in Acute Ischemic Stroke Associated With 3-Month Unfavorable Outcome
por: Sun, Huanhuan, et al.
Publicado: (2022)

Ischemic Stroke Hospital Admission Associated with Ambient Temperature in Jinan, China
por: Wang, Qinzhou, et al.
Publicado: (2013)

Resveratrol represses YKL-40 expression in human glioma U87 cells
por: Zhang, Wei, et al.
Publicado: (2010)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n2vn502d6dtmu3a8nmshijperg